Rangeley Capital’s Akoya BioSciences AKYA Stock Holding History
Bought
Maintained
Sold
Rangeley Capital's AKYA Position: Q3 2025 in Review
Rangeley Capital sold out of Akoya BioSciences (AKYA) in Q3 2025, closing a stake of 33,035 shares — an estimated $42.9K sold.
Rangeley Capital first reported a position in AKYA in Q2 2025 and held it in 1 quarter. The position peaked at $42.9K in Q2 2025. 0 funds tracked by Wall St. Rank hold AKYA as of Q3 2025.
- Rangeley Capital reported no remaining Akoya BioSciences position as of Q3 2025 after selling out during the quarter.
- Rangeley Capital sold 33,035 Akoya BioSciences shares in Q3 2025, an estimated $42.9K.
- Rangeley Capital first reported a position in Akoya BioSciences in Q2 2025 and held it in 1 quarter.
- Rangeley Capital's Akoya BioSciences position peaked at $42.9K in Q2 2025.
- 0 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2025.
Based on Rangeley Capital's 13F filing for Q3 2025, filed 14 Nov 2025.